121 related articles for article (PubMed ID: 9299208)
21. Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism.
Bonanno G; Fassio A; Severi P; Ruelle A; Raiteri M
J Neurochem; 1994 Sep; 63(3):1163-6. PubMed ID: 8051559
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of voltage-gated Ca2+ channels and insulin secretion in HIT cells by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-62: comparison with antagonists of calmodulin and L-type Ca2+ channels.
Li G; Hidaka H; Wollheim CB
Mol Pharmacol; 1992 Sep; 42(3):489-8. PubMed ID: 1328847
[TBL] [Abstract][Full Text] [Related]
23. Relation of exocytotic release of gamma-aminobutyric acid to Ca2+ entry through Ca2+ channels or by reversal of the Na+/Ca2+ exchanger in synaptosomes.
Duarte CB; Ferreira IL; Carvalho AP; Carvalho CM
Pflugers Arch; 1993 May; 423(3-4):314-23. PubMed ID: 8391683
[TBL] [Abstract][Full Text] [Related]
24. Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser.
Gobbi M; Mennini T
Eur J Pharmacol; 1999 Apr; 370(1):23-6. PubMed ID: 10323276
[TBL] [Abstract][Full Text] [Related]
25. Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma.
Williams CL; Phelps SH; Porter RA
Biochem Pharmacol; 1996 Mar; 51(5):707-15. PubMed ID: 8615909
[TBL] [Abstract][Full Text] [Related]
26. Differences in regulation of Ca(2+)-activated Cl- channels in colonic and parotid secretory cells.
Arreola J; Melvin JE; Begenisich T
Am J Physiol; 1998 Jan; 274(1):C161-6. PubMed ID: 9458724
[TBL] [Abstract][Full Text] [Related]
27. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
Tokumitsu H; Chijiwa T; Hagiwara M; Mizutani A; Terasawa M; Hidaka H
J Biol Chem; 1990 Mar; 265(8):4315-20. PubMed ID: 2155222
[TBL] [Abstract][Full Text] [Related]
28. Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]serotonin.
Gobbi M; Frittoli E; Mennini T; Garattini S
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):1-6. PubMed ID: 1538789
[TBL] [Abstract][Full Text] [Related]
29. Exocytosis elicited by action potentials and voltage-clamp calcium currents in individual mouse pancreatic B-cells.
Ammälä C; Eliasson L; Bokvist K; Larsson O; Ashcroft FM; Rorsman P
J Physiol; 1993 Dec; 472():665-88. PubMed ID: 8145165
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones.
Holohean AM; Hackman JC
Br J Pharmacol; 2004 Oct; 143(3):351-60. PubMed ID: 15339859
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase C modulates the release of [3H]5-hydroxytryptamine in the spinal cord of the rat: the role of L-type voltage-dependent calcium channels.
Gandhi VC; Jones DJ
Neuropharmacology; 1992 Nov; 31(11):1101-9. PubMed ID: 1282220
[TBL] [Abstract][Full Text] [Related]
32. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation.
Barria A; Muller D; Derkach V; Griffith LC; Soderling TR
Science; 1997 Jun; 276(5321):2042-5. PubMed ID: 9197267
[TBL] [Abstract][Full Text] [Related]
33. Possible involvement of calmodulin-dependent kinases in Ca(2+)-dependent enhancement of [3H]5-hydroxytryptamine uptake in rat cortex.
Yura A; Kiuchi Y; Uchikawa T; Uchida J; Yamazaki K; Oguchi K
Brain Res; 1996 Oct; 738(1):96-102. PubMed ID: 8949931
[TBL] [Abstract][Full Text] [Related]
34. Genistein inhibits Ca2+ influx and glutamate release from hippocampal synaptosomes: putative non-specific effects.
Pereira DB; Carvalho AP; Duarte CB
Neurochem Int; 2003 Jan; 42(2):179-88. PubMed ID: 12421598
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of calmodulin-dependent protein kinase are nonspecific blockers of voltage-dependent K+ channels in vascular myocytes.
Ledoux J; Chartier D; Leblanc N
J Pharmacol Exp Ther; 1999 Sep; 290(3):1165-74. PubMed ID: 10454491
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia.
Raiteri M; Bonanno G; Vallebuona F
J Pharmacol Exp Ther; 1995 May; 273(2):643-9. PubMed ID: 7752066
[TBL] [Abstract][Full Text] [Related]
37. Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles.
Kantor L; Hewlett GH; Gnegy ME
J Neurosci; 1999 May; 19(10):3801-8. PubMed ID: 10234012
[TBL] [Abstract][Full Text] [Related]
38. Non-specific effects of the MEK inhibitors PD098,059 and U0126 on glutamate release from hippocampal synaptosomes.
Pereira DB; Carvalho AP; Duarte CB
Neuropharmacology; 2002 Jan; 42(1):9-19. PubMed ID: 11750912
[TBL] [Abstract][Full Text] [Related]
39. Effect of calcium on the uptake of glutamate by synaptosomes: possible involvement of two different mechanisms.
Zhu BG; Chen YZ; Xing BR
J Neural Transm (Vienna); 1999; 106(3-4):257-64. PubMed ID: 10392534
[TBL] [Abstract][Full Text] [Related]
40. Intracellular application of calmidazolium increases Ca2+ current through activation of protein kinase A in cultured vascular smooth muscle cells.
Sunagawa M; Yokoshiki H; Seki T; Sperelakis N
J Vasc Res; 1998; 35(5):303-9. PubMed ID: 9789110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
